Home › Neuroblastoma › Michigan › Grand Rapids
Neuroblastoma clinical trials in Grand Rapids, MI
4 studies for Neuroblastoma are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Corewell Health ( Site 1001), Grand Rapids
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RecruitingPhase 2
- Helen DeVos Children's Hospital, Grand Rapids
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
- Aurora, CO8 studies
- Hartford, CT8 studies
- Minneapolis, MN8 studies
- Birmingham, AL8 studies
- Atlanta, GA7 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer44 studies
- Colorectal Cancer40 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Ovarian Cancer24 studies
- Metastatic Cancer22 studies
- Prostate Cancer19 studies
- Endometrial Cancer18 studies
- Stomach Cancer18 studies
- Pancreatic Cancer18 studies
- Melanoma17 studies
- Triple-Negative Breast Cancer15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.